US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.420
  • -0.030-0.22%
Close Dec 13 16:00 ET
  • 13.260
  • -0.160-1.19%
Post 19:24 ET
42.70BMarket Cap22.52P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com

Company Executives

  • Name
  • Position
  • Salary
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.04%